Pregnancy and postpartum psychiatric episodes in fathers: A population-based study on treatment incidence and prevalence.

Fathers Incidence Perinatal psychiatric episodes Postpartum depression Prevalence Register-based population study

Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
01 01 2022
Historique:
received: 17 03 2021
revised: 20 08 2021
accepted: 16 09 2021
pubmed: 4 10 2021
medline: 27 1 2022
entrez: 3 10 2021
Statut: ppublish

Résumé

For women, the perinatal period confers an increased risk of severe psychiatric disorders, but similar evidence for fathers is lacking. We examined rates of first-time and recurrent psychiatric disorders in men before and after becoming fathers. A descriptive prospective study design was applied using information from the Danish National registers. Perinatal psychiatric episodes were assessed as incidence of first-time and prevalence (including recurrence) of recorded in- or outpatient admissions for any mental disorder and redeemed prescriptions for psychotropic medication in fathers to children born from January 1, 1998 until December 31, 2015. We identified 929,415 births and 543,555 unique fathers. Incidence and prevalence proportions for paternal psychiatric in- and outpatient episodes showed an increasing trend over the perinatal period and were marginally higher postpartum compared to pregnancy; e.g., median incidence proportion for inpatient treatment during pregnancy was 0.07 (95% CI: 0.04; 0.07) and 0.10 (95% CI: 0.08; 0.11) postpartum per 1000 births. No difference between the periods was found for incidence of prescriptions for psychotropic medication. Psychiatric disorders in expecting and new fathers were mainly treated in primary care with cumulative incidence of prescriptions for psychotropic medication of 14.56 per 1000 births during the first year of fatherhood. We only capture fathers who actively sought and received treatment, and we consequently underestimate milder psychiatric episodes in expecting and new fathers. Becoming a father did not appear to trigger a substantially increased risk of severe psychiatric disorders, as it has been observed for new mothers.

Sections du résumé

BACKGROUND
For women, the perinatal period confers an increased risk of severe psychiatric disorders, but similar evidence for fathers is lacking. We examined rates of first-time and recurrent psychiatric disorders in men before and after becoming fathers.
METHODS
A descriptive prospective study design was applied using information from the Danish National registers. Perinatal psychiatric episodes were assessed as incidence of first-time and prevalence (including recurrence) of recorded in- or outpatient admissions for any mental disorder and redeemed prescriptions for psychotropic medication in fathers to children born from January 1, 1998 until December 31, 2015.
RESULTS
We identified 929,415 births and 543,555 unique fathers. Incidence and prevalence proportions for paternal psychiatric in- and outpatient episodes showed an increasing trend over the perinatal period and were marginally higher postpartum compared to pregnancy; e.g., median incidence proportion for inpatient treatment during pregnancy was 0.07 (95% CI: 0.04; 0.07) and 0.10 (95% CI: 0.08; 0.11) postpartum per 1000 births. No difference between the periods was found for incidence of prescriptions for psychotropic medication. Psychiatric disorders in expecting and new fathers were mainly treated in primary care with cumulative incidence of prescriptions for psychotropic medication of 14.56 per 1000 births during the first year of fatherhood.
LIMITATIONS
We only capture fathers who actively sought and received treatment, and we consequently underestimate milder psychiatric episodes in expecting and new fathers.
CONCLUSION
Becoming a father did not appear to trigger a substantially increased risk of severe psychiatric disorders, as it has been observed for new mothers.

Identifiants

pubmed: 34601300
pii: S0165-0327(21)01015-6
doi: 10.1016/j.jad.2021.09.056
pmc: PMC8595874
mid: NIHMS1745040
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

130-135

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH122869
Pays : United States

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Références

Arch Pediatr Adolesc Med. 2010 Nov;164(11):1038-44
pubmed: 20819960
J Affect Disord. 2016 Dec;206:189-203
pubmed: 27475890
J Neurosci Res. 2017 Jan 2;95(1-2):719-730
pubmed: 27870443
Lancet. 2005 Jun 25-Jul 1;365(9478):2201-5
pubmed: 15978928
Br J Psychiatry. 2016 May;208(5):462-9
pubmed: 26494874
Psychol Med. 2020 Jul;50(9):1563-1569
pubmed: 31298172
J Affect Disord. 2020 Jan 1;260:629-637
pubmed: 31542556
JAMA. 2006 Dec 6;296(21):2582-9
pubmed: 17148723
J Affect Disord. 2016 Jan 15;190:675-686
pubmed: 26590515
Arch Womens Ment Health. 2005 Jun;8(2):77-87
pubmed: 15883651
JAMA. 2010 May 19;303(19):1961-9
pubmed: 20483973
N Engl J Med. 2016 Dec;375(22):2177-2186
pubmed: 27959754
Nat Rev Dis Primers. 2018 Apr 26;4:18022
pubmed: 29695824
BMC Pregnancy Childbirth. 2017 Jan 26;17(1):45
pubmed: 28125983
J Adv Nurs. 2004 Jan;45(1):26-35
pubmed: 14675298
Psychiatry (Edgmont). 2007 Feb;4(2):35-47
pubmed: 20805898
Am J Psychiatry. 2000 Jun;157(6):924-30
pubmed: 10831472
Transl Psychiatry. 2016 Oct 18;6(10):e919
pubmed: 27754485
J Affect Disord. 2000 Nov;60(2):75-85
pubmed: 10967366
Am J Mens Health. 2015 Jan;9(1):26-34
pubmed: 24626601
J Affect Disord. 2020 Feb 15;263:491-499
pubmed: 31757623
Brain Behav Immun. 2020 Jul;87:397-403
pubmed: 31926288
Scand J Public Health. 2011 Jul;39(7 Suppl):54-7
pubmed: 21775352
Br J Psychiatry. 1987 Jun;150:782-6
pubmed: 3651732
Arch Gen Psychiatry. 2009 Feb;66(2):189-95
pubmed: 19188541
Scand J Public Health. 2011 Jul;39(7 Suppl):22-5
pubmed: 21775345
Lancet. 2014 Nov 15;384(9956):1775-88
pubmed: 25455248
Scand J Public Health. 2011 Jul;39(7 Suppl):38-41
pubmed: 21775349
Perspect Public Health. 2019 Jul;139(4):195-198
pubmed: 30044191
Obstet Gynecol. 2005 Nov;106(5 Pt 1):1071-83
pubmed: 16260528

Auteurs

Kathrine Bang Madsen (KB)

National Centre for Register-based Research, Business and Social Sciences, Aarhus University, Fuglesangs Allé 26, Building R, Aarhus 8210, Denmark; iPSYCH, the Lundbeck Foundation Initiative for Integrative Psychiatric Research, Denmark. Electronic address: kathrine.bang@econ.au.dk.

Merete Lund Mægbæk (ML)

National Centre for Register-based Research, Business and Social Sciences, Aarhus University, Fuglesangs Allé 26, Building R, Aarhus 8210, Denmark; iPSYCH, the Lundbeck Foundation Initiative for Integrative Psychiatric Research, Denmark.

Nete Stubkjær Thomsen (NS)

National Centre for Register-based Research, Business and Social Sciences, Aarhus University, Fuglesangs Allé 26, Building R, Aarhus 8210, Denmark; iPSYCH, the Lundbeck Foundation Initiative for Integrative Psychiatric Research, Denmark.

Xiaoqin Liu (X)

National Centre for Register-based Research, Business and Social Sciences, Aarhus University, Fuglesangs Allé 26, Building R, Aarhus 8210, Denmark; iPSYCH, the Lundbeck Foundation Initiative for Integrative Psychiatric Research, Denmark.

Malin Eberhard-Gran (M)

Norwegian Research Centre for Women's Health, Women and Children's Division, Oslo University Hospital, Rikshospitalet, Oslo Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Alkistis Skalkidou (A)

Department of Women's and Children's Health, Uppsala University, Sweden.

Veerle Bergink (V)

Department of Psychiatry and Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, NY, USA; Department of Psychiatry, Rotterdam, Erasmus MC, the Netherlands.

Trine Munk-Olsen (T)

National Centre for Register-based Research, Business and Social Sciences, Aarhus University, Fuglesangs Allé 26, Building R, Aarhus 8210, Denmark; iPSYCH, the Lundbeck Foundation Initiative for Integrative Psychiatric Research, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH